These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 25522403

  • 1. Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.
    Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, Wadsak W, Lanzenberger R, Kasper S.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(4):. PubMed ID: 25522403
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.
    Kasper S, Anghelescu I, Dienel A.
    Eur Neuropsychopharmacol; 2015 Nov 31; 25(11):1960-7. PubMed ID: 26293583
    [Abstract] [Full Text] [Related]

  • 3. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.
    Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S.
    Int Clin Psychopharmacol; 2010 Sep 31; 25(5):277-87. PubMed ID: 20512042
    [Abstract] [Full Text] [Related]

  • 4. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
    Zanderigo F, Pantazatos S, Rubin-Falcone H, Ogden RT, Chhetry BT, Sullivan G, Oquendo M, Miller JM, Mann JJ.
    Brain Struct Funct; 2018 Jul 31; 223(6):2609-2625. PubMed ID: 29550938
    [Abstract] [Full Text] [Related]

  • 5. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H, Schläfke S.
    Phytomedicine; 2010 Feb 31; 17(2):94-9. PubMed ID: 19962288
    [Abstract] [Full Text] [Related]

  • 6. No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial.
    Seifritz E, Möller HJ, Volz HP, Müller WE, Hopyan T, Wacker A, Schläfke S, Kasper S.
    Int J Neuropsychopharmacol; 2021 Mar 17; 24(3):171-180. PubMed ID: 33300578
    [Abstract] [Full Text] [Related]

  • 7. An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.
    Kasper S.
    Int J Psychiatry Clin Pract; 2013 Nov 17; 17 Suppl 1():15-22. PubMed ID: 23808618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge J, Ziolko SK, McConaha CW, Kaye WH.
    Arch Gen Psychiatry; 2005 Sep 17; 62(9):1032-41. PubMed ID: 16143735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.